Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2022-01-10 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
110年12月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 科妍, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no voting results, no legal or regulatory announcements, and no mention of any report publication or certification. The content is a regulatory disclosure of financial guarantees and loans, typical of a general regulatory announcement. The document length is very short (601 characters), and it does not indicate it is an announcement of a report or a report itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2022-01-10 Chinese
110年12月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 科妍, with comparisons to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (765 characters) and it primarily provides financial summary data without detailed financial statements or analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It is also not an announcement of a report publication or a certification. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial data without the depth of a full report or presentation.
2022-01-10 Chinese
110年12月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related data. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but the actual disclosure of insider shareholdings and transactions. Therefore, the appropriate classification is Director's Dealing (DIRS).
2022-01-07 Chinese
110年12月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors and senior management, with specific numbers of shares held, pledged shares, and related percentages. It lists individual names, titles, and shareholding details. This type of document is characteristic of a Director's Dealing report, which discloses personal share transactions or holdings by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document length is relatively short (2471 characters), and it is not an announcement of a report but a direct disclosure of insider shareholdings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2022-01-07 Chinese
轉換公司債
Regulatory Filings Classification · 100% confidence The document text contains only the phrase '查無資料' which translates to 'No data found' and is extremely short (27 characters). There is no substantive content, financial data, or any report-related information. This indicates it is likely a placeholder or an empty regulatory announcement with no actual report attached or referenced. According to the rules, such minimal content with no report is best classified as a Regulatory Filing (RNS), the fallback category for miscellaneous filings without substantive content.
2022-01-01 Chinese
110年11月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related data. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full financial report, earnings release, or regulatory announcement about voting or dividends. The document is a report of personal share transactions by company directors and executives, which matches the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just an announcement or certification.
2021-12-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.